ALGGF yields 1.37% · JNJ yields 2.13%● Live data
📍 ALGGF pulled ahead of the other in Year 1
Combined, ALGGF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of ALGGF + JNJ for your $10,000?
Alliance Global Group, Inc., together with its subsidiaries, engages in real estate development, tourism-entertainment and gaming, food and beverage, quick-service restaurant, and infrastructure development businesses in the Philippines and internationally. The company operates through Megaworld, Emperador, Travellers, and GADC segments. It develops residential condominium units, subdivision lots, and townhouses, as well as office and retail developments; sells townhouses and tourism estate properties; develops integrated resorts; leases office and retail spaces; and operates and manages hotels. The company also develops and operates Resorts World Manila, an integrated tourism resort; and operates NEWPORT mall. In addition, it produces glass containers, as well as manufactures, bottles, and distributes distilled spirits and other alcoholic beverages under the Emperador Light, Emperador Deluxe, Andy Player Whisky, Smirnoff Mule, The BaR, The Dalmore, Jura Scotch, and Fundador brands. Further, the company operates franchised McDonald's restaurants in the Philippines. Additionally, it distributes wines, whisky and brandy products, and shoestring-shaped potato snacks. Alliance Global Group, Inc. was incorporated in 1993 and is based in Quezon City, the Philippines.
Full ALGGF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.